Jeffrey A. Bluestone
Gladstone Institutes · 706 works · 101,923 citations · h-index 162
Top works
- Identification of a monoclonal antibody specific for a murine T3 polypeptide.
- Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4
- CD28/B7 SYSTEM OF T CELL COSTIMULATION
- CTLA-4 can function as a negative regulator of T cell activation
- B7/CD28 Costimulation Is Essential for the Homeostasis of the CD4+CD25+ Immunoregulatory T Cells that Control Autoimmune Diabetes
- The B7 and CD28 receptor families
- Long-Term Survival of Xenogeneic Pancreatic Islet Grafts Induced by CTLA4lg
- CTLA-4 ligation blocks CD28-dependent T cell activation.
- CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
- Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4
- Innate immunity and intestinal microbiota in the development of Type 1 diabetes
- Natural versus adaptive regulatory T cells
- International Trial of the Edmonton Protocol for Islet Transplantation
- Complexities of CD28/B7: CTLA-4 Costimulatory Pathways in Autoimmunity and Transplantation
- Differential expression of two distinct T-cell receptors during thymocyte development
- Characterization of murine thymocytes with CDS-associated T-cell receptor structures
- CTLA-4: a negative regulator of autoimmune disease.
- Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse.
- Anti-CD3 Monoclonal Antibody in New-Onset Type 1 Diabetes Mellitus
- Absence of B7-dependent responses in CD28-deficient mice